HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].

AbstractOBJECTIVES:
To analyse neonatal effects after in utero selective serotonin reuptake inhibitors exposure and the pertinence of recommendations delivered by our team.
MATERIALS AND METHODS:
We report a series of 27 pregnancies exposed late in pregnancy including the period of delivery, to the Selective Serotonin Reuptake Inhibitors (SSRI) and having been the subject of a call to the Regional Center of Pharmacovigilance of Tours (CRPV).
RESULTS:
Twenty-seven children were born without malformation. Twelve children were hospitalized because of prematurity (two), exposure to other drugs imposing particular surveillance (eight) or in view of abnormal neonatal effects (two). Five newborns (18.5%) of which three had also been exposed to other drugs (benzodiazepine, neuroleptic, H1-antagonist) had presented one or more neonatal adverse effects compatible with the role of the SSRI (irritability, agitation, shivering, hypotonia) but with uncertainty about a clear discrimination between withdrawal syndrome and serotonin impregnation. All the symptoms disappeared spontaneously. One of the five children had a described in treated adults but two neonatal observations were published. No child had hemorrhagic symptoms as described in treated adults despite the fact that two neonatal observations were reported.
CONCLUSION:
This study confirms the relative benignity of SSRI exposure during late pregnancy. Our recommendations for monitoring the newborns during their stay in maternity wards were well respected. The risk of hemorrhagic symptoms or hyponatremia, not well known by pediatricians, deserves to be recalled to medical teams who take in charge newborns exposed to SSRI.
AuthorsH Cissoko, D Swortfiguer, B Giraudeau, A-P Jonville-Béra, E Autret-Leca
JournalArchives de pediatrie : organe officiel de la Societe francaise de pediatrie (Arch Pediatr) Vol. 12 Issue 7 Pg. 1081-4 (Jul 2005) ISSN: 0929-693X [Print] France
Vernacular TitleExposition aux antidépresseurs inhibiteurs de la recapture de la sérotonine (IRS) en fin de grossesse: retentissement néonatal.
PMID15964522 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antidepressive Agents, Second-Generation
  • Serotonin Uptake Inhibitors
Topics
  • Adult
  • Antidepressive Agents, Second-Generation (administration & dosage, adverse effects)
  • Depression (drug therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Infant, Newborn
  • Medical Records
  • Neonatal Abstinence Syndrome (etiology)
  • Pregnancy
  • Pregnancy Complications (drug therapy)
  • Pregnancy Outcome
  • Pregnancy Trimester, Third
  • Retrospective Studies
  • Selective Serotonin Reuptake Inhibitors (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: